Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
126.41B
Market cap126.41B
Price-Earnings ratio
26.60
Price-Earnings ratio26.60
Dividend yield
2.86%
Dividend yield2.86%
Average volume
6.35M
Average volume6.35M
High today
$99.25
High today$99.25
Low today
$98.22
Low today$98.22
Open price
$98.75
Open price$98.75
Volume
12.76M
Volume12.76M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$79.29
52 Week low$79.29

Stock Snapshot

As of today, Medtronic(MDT) shares are valued at $99.03. The company's market cap stands at 126.41B, with a P/E ratio of 26.60 and a dividend yield of 2.9%.

On 2025-12-19, Medtronic(MDT) stock moved within a range of $98.22 to $99.25. With shares now at $99.03, the stock is trading +0.8% above its intraday low and -0.2% below the session's peak.

Trading volume for Medtronic(MDT) stock has reached 12.76M, versus its average volume of 6.35M.

Over the past 52 weeks, Medtronic(MDT) stock has traded between a high of $106.33 and a low of $79.29.

Over the past 52 weeks, Medtronic(MDT) stock has traded between a high of $106.33 and a low of $79.29.

MDT News

Simply Wall St 32m
Is Medtronic Fairly Priced After Its Portfolio Streamlining and Robotics Growth Push in 2025?

If you have been wondering whether Medtronic is still a buy at around $98 a share, you are not alone. This article is designed to unpack what that price really...

Is Medtronic Fairly Priced After Its Portfolio Streamlining and Robotics Growth Push in 2025?
Yahoo Finance 2h
Medtronic’s diabetes management business MiniMed files for IPO - Yahoo Finance

...

Medtronic’s diabetes management business MiniMed files for IPO - Yahoo Finance
The Wall Street Journal 3h
Medtronic Spin-Off MiniMed Files for IPO

The Medtronic subsidiary, which makes medical technology for diabetes patients, didn’t say how many shares it would offer or at what price. Jenn Ackerman for WS...

Medtronic Spin-Off MiniMed Files for IPO

Analyst ratings

53%

of 34 ratings
Buy
52.9%
Hold
47.1%
Sell
0%

More MDT News

Seeking Alpha 4h
Medtronic’s diabetes unit MiniMed files for IPO

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from pr...

Medtronic’s diabetes unit MiniMed files for IPO
TipRanks 4h
Medtronic announces filing of IPO registration for MiniMed

Medtronic (MDT) announced that its diabetes business, which as previously announced will operate under the name MiniMed (MMED), has filed a registration stateme...

Simply Wall St 1d
What Medtronic's Dividend Hike and FDA-Cleared Hugo Robot Mean For Shareholders

In early December 2025, Medtronic’s board approved a US$0.71 per-share cash dividend for the third quarter of fiscal 2026, payable on January 16, 2026, to share...

What Medtronic's Dividend Hike and FDA-Cleared Hugo Robot Mean For Shareholders
TipRanks 1d
Medtronic price target lowered to $107 from $110 at Truist

Truist analyst Richard Newitter lowered the firm’s price target on Medtronic (MDT) to $107 from $110 and keeps a Hold rating on the shares as part of a broader...

Simply Wall St 3d
Revisiting Medtronic: Assessing Valuation After This Year’s Steady Share Price Climb

Medtronic stock moves Medtronic (MDT) has been quietly grinding higher this year, and recent trading action is giving investors a fresh reason to revisit the s...

Revisiting Medtronic: Assessing Valuation After This Year’s Steady Share Price Climb
Nasdaq 5d
This Dividend Stock Just Hit a Major Milestone. Time to Buy?

Key Points Medtronic earned regulatory clearance in the U.S. for its Hugo robotic-assisted surgery system. This device will take time to have a material impac...

This Dividend Stock Just Hit a Major Milestone. Time to Buy?

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.